Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00696852 · ClinicalTrials.gov registry record · NA

Mindfulness, Yoga, and Cardiovascular Disease

A NA study of Depression and Anxiety, sponsored by The Cleveland Clinic.

Completed
Registry status
NA
Development phase
64
Enrollment target
1
Study location

NCT00696852: Completed NA study of Depression and Anxiety, sponsored by The Cleveland Clinic.

NCT00696852 is a NA study of Depression and Anxiety that has completed, run by The Cleveland Clinic. The registered enrollment target is 64 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00696852, a NA study of Depression and Anxiety, has completed, sponsored by The Cleveland Clinic.

COMPLETED
Registry status
NA
Development phase
64 participants
Enrollment target
1
Study location

Study Summary

In this study, we will conduct a preliminary, yet comprehensive evaluation of Mindfulness and Yoga, as compared to an exercise and education-based stress-reduction program. and simultaneous evaluation of the effect of an 8 week program of Mindfulness, 12 weeks of Yoga practice, and 12 weeks of an exercise and education-based program. 105 otherwise healthy individuals, who have cardiovascular risk factors and mild to moderate stress or anxiety will be randomly assigned to one of the three intervention groups: an 8 week program of Mindfulness, 12 week program of Yoga practice, and 12 week exercise and education-based group program. All subjects will perform daily practice that will continue after the weekly sessions end, allowing a follow up assessment at 24 weeks. Self-reported mood and psychological distress and physiological indicators of function of the ANS and stress hormones will be assessed at baseline, 8 weeks, 12 weeks and 24 weeks. Blood and urine samples will be collected at baseline and 8 weeks to determine levels inflammatory and atherosclerosis markers. We anticipate that the study will provide information on the efficacy of the Mindfulness and Yoga interventions as stress-reduction practices, variability in potential markers for activation of the brain/cardiovascular system connections, and preliminary estimates of effect size for each of these markers. Thus, the study will provide the data needed for designing a future study that will rigorously address these questions in a larger, randomized trial of Mindfulness and Yoga in patients with cardiovascular risk.

Interventions

  • BEHAVIORAL Yoga
  • BEHAVIORAL Mindfulness Meditation
  • BEHAVIORAL Exercise, Relaxation, and Health Education

Study Locations (1)

Ohio

  • The Cleveland Clinic - Cleveland

Trial Details

FieldValue
Enrollment Target 64 participants
Start Date 2008-06
Est. Completion 2009-05
Phase NA
The Cleveland Clinic

688 total trials

What the finished NCT00696852 record still lists

NCT00696852 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 64 participants, a relatively small participant target, below the 786-participant average among 679 other Depression trials with a reported enrollment target (92% lower).

The record links to 4 conditions, with Depression appearing as the primary indexed condition, and to 3 interventions - of which Yoga is the first listed.

NCT00696852 reports a single indexed study location in Ohio.

Frequently Asked Questions

What is clinical trial NCT00696852 about?

NCT00696852 is a clinical study titled "Mindfulness, Yoga, and Cardiovascular Disease". In this study, we will conduct a preliminary, yet comprehensive evaluation of Mindfulness and Yoga, as compared to an exercise and education-based stress-reduction program. and simultaneous evaluation of the effect of an 8 week program of Mindfulness, 12 weeks of Yoga practice, and 12 weeks of an ex...

What is the current status of trial NCT00696852?

This trial is currently completed. It is a NA study. The enrollment target is 64 participants. The study started on 2008-06. Estimated completion is 2009-05.

What conditions does trial NCT00696852 study?

This clinical trial studies the following conditions: Depression, Anxiety, Stress, Cardiovascular Disease.

What interventions are being tested in trial NCT00696852?

The interventions under investigation include: Yoga (BEHAVIORAL), Mindfulness Meditation (BEHAVIORAL), Exercise, Relaxation, and Health Education (BEHAVIORAL).

Who is sponsoring clinical trial NCT00696852?

This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00696852 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Depression

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00696852's enrollment target sits among peer trials

64 421st of 679 higher than 255 of 679 other Depression trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Depression trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01853631 · 64 participants · Phase 1

    Activated T-Cells Expressing 2nd or 3rd Generation CD19-Specific CAR, Advanced B-Cell NHL, ALL, and CLL (SAGAN)

  • NCT03739502 · 64 participants · Phase 2

    A Randomized Phase II Study of Hyperbaric Oxygen in Improving Engraftment in Umbilical Cord Blood Stem Cell Transplant

  • NCT03739814 · 64 participants · Phase 2

    Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia

  • NCT03866408 · 64 participants · Early Phase 1

    Insulin Regulation of Lipolysis and Lipolysis Proteins

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00696852, the US trial registry maintained by the National Library of Medicine. NCT00696852 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.